Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(0)
# 4440
Out of 5,298 analysts
63
Total ratings
19.57%
Success rate
-16.75%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TVTX Travere Therapeutics | Reiterates: Overweight | n/a | n/a | n/a | 2 | Apr 3, 2025 | |
ACRS Aclaris Therapeutics | Reiterates: Overweight | n/a | n/a | n/a | 1 | Mar 18, 2025 | |
MTSR Metsera | Initiates Coverage On: Overweight | n/a | n/a | n/a | 1 | Feb 25, 2025 | |
KROS Keros Therapeutics | Downgrades: Neutral | n/a | n/a | n/a | 3 | Jan 21, 2025 | |
ORIC ORIC Pharmaceuticals | Reiterates: Overweight | n/a | n/a | n/a | 6 | Jan 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | n/a | n/a | n/a | 1 | Jan 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 10 | 5.22 | 91.57% | 1 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 4 | Nov 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 65 65 | 15.14 | 329.33% | 12 | Sep 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 10 | Sep 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 5 | Jun 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 13 15 | n/a | n/a | 2 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 58 48 | n/a | n/a | 2 | Jun 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 24 | 37.33 | -35.71% | 2 | Apr 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 1 | n/a | n/a | 1 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 450 | 3.03 | 14751.49% | 1 | Jul 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 21 | n/a | n/a | 2 | Jun 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 390 | n/a | n/a | 1 | Sep 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | n/a | n/a | 1 | May 18, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Mar 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 14 | 0.47 | 2878.72% | 1 | Mar 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 6 | n/a | n/a | 1 | Mar 4, 2020 |